INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/01/2026
Back to search
Official data from USPTO
PRADAXA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
08/01/2026
Trademark type
Combined
Nice classes
5
Filing date
04/06/2016
Registration date
04/04/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/01/2025
Last transaction
08/01/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
Ingelheim, DE
Examiner
WHITTAKER BROWN, TRACY
Current location
POST REGISTRATION
Mark description
The mark consists of the blue stylized term PRADAXA with a design featuring incomplete concentric ovals. The inner oval is red and the outer is blue. The background of the mark is negative space that will appear in the color of the surface upon which the mark is placed.
Holders and representatives
Holders
Boehringer Ingelheim Pharma GmbH & Co KG
Boehringer Ingelheim Pharma GmbH & Co KG
Representatives
Max Moskowitz Ostrolenk Faber LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolismblood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular systemmusculoskeletal systemcentral nervous systemperipheral nervous systemgenitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatologicalhormonalinfectiousviral and oncological diseases and disorders
Publications
History of USPTO decisions and trademark events.
38 publications found
NC71
NOTICE OF CANCELLATION SEC. 71 E-MAILED
12/01/2025
C71T
CANCELLED SECTION 71
12/01/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/05/2025
PUM2
OFFICE ACTION ISSUED POU2
12/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/05/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
02/08/2024
PUMI
PROOF OF USE INTERIM ACTION ISSUED
09/27/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09/22/2023
PUM1
OFFICE ACTION ISSUED POU1
03/31/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/31/2023
ES71
TEAS SECTION 71 RECEIVED
03/16/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/04/2022
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
07/28/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/08/2017
FIMP
FINAL DISPOSITION PROCESSED
07/08/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/04/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/17/2017
PUBO
PUBLISHED FOR OPPOSITION
01/17/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/28/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/03/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/30/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/30/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/30/2016
RFNT
REFUSAL PROCESSED BY IB
11/25/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/21/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/10/2016
RFRR
REFUSAL PROCESSED BY MPU
11/10/2016
MAFR
APPLICATION FILING RECEIPT MAILED
10/22/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/20/2016
CNRT
NON-FINAL ACTION WRITTEN
10/19/2016
DOCK
ASSIGNED TO EXAMINER
10/18/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/18/2016
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/17/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/17/2016
Continuous trademark protection
Get notified about every new filing that threatens PRADAXA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.